Pacira BioSciences (PCRX) EPS (Basic) (2010 - 2026)
Pacira BioSciences (PCRX) recorded quarterly EPS (Basic) of $0.07 in Q1 2026, up 75.0% quarter-over-quarter from $0.04 in Q4 2025, and down 30.0% on a YoY basis from $0.1 in Q1 2025.
Pacira BioSciences (PCRX) EPS (Basic) (2010 - 2026) Analysis & Trends
Pacira BioSciences' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.07 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 30.0% year-over-year to $0.07; the TTM figure through Mar 2026 stood at $0.12 (up 105.33% YoY), while the FY2025 annual figure was $0.16, up 107.44% from the prior year.
- EPS (Basic) was $0.07 for Q1 2026 at Pacira BioSciences, up from $0.04 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.56 in Q2 2023 to a low of -$3.11 in Q3 2024.
- Historically, EPS (Basic) has averaged -$0.04 across 5 years, with a median of $0.12 in 2025.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) jumped 1250.0% in 2023, then plunged 1452.17% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.22 in 2022, then soared by 345.45% to $0.54 in 2023, then tumbled by 35.19% to $0.35 in 2024, then sank by 88.57% to $0.04 in 2025, then soared by 75.0% to $0.07 in 2026.
- The last three EPS (Basic) figures came in at $0.07 (Q1 2026), $0.04 (Q4 2025), and $0.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.32 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.32 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.97 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.83 |
| 10 | Pacira BioSciences | 940.31 Mn | 738.13 Mn | 140.96 Mn | 0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | 0.10 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | -3.11 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.54 |
| Sep 30, 2023 | 0.23 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.22 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.15 |
| Dec 31, 2021 | -0.12 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.43 |